Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.
Terms of UseThe Medivation website is designed to provide general information about Medivation’s strategy, history and product development. It is not intended to provide medical information or investment advice. Access to and use of the Medivation website is subject to all applicable laws and to the terms and conditions set forth below. Medivation intends to keep the information on this website current, but makes no representation as to its accuracy or completeness. Use of this website is at your own risk, and Medivation accepts no liability for damages occurring from the use of information on this site. This website contains forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including statements regarding anticipated future clinical and regulatory milestones. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward-looking statements. Our filings with the Securities and Exchange Commission include more information about factors that could affect our financial and operating results. Medivation may revise these terms without prior notice and will post those revisions here. Privacy PolicyMedivation does not collect or use information from visitors to its website except for the following contacts voluntarily initiated by website visitors: E-Mail or Postal Alerts and InformationMedivation will collect name, e-mail address, company name and focus, telephone, fax, and postal address information as voluntarily submitted by website visitors wishing to be informed of news or events related to Medivation, or those wishing investor information. Use of that information will be strictly for the purpose of sending these alerts and investor information, and will not be shared with outside parties except as needed to meet that request. Contact UsMedivation will collect contact information and content for any e-mail, fax, telephone call, or letter we receive. Use of that information will depend upon the content of the e-mail, fax, telephone call, or letter, but will not be shared with outside parties except as needed to respond to the content of that contact. |
 |
 |
| Medivation © 2010 |